Review
Accepted on 13 Apr 2026
Digital Pathology and Artificial Intelligence in Breast and Gynecologic Oncology: From Molecular Prediction to Multimodal Integration
in Molecular and Cellular Oncology
Frontiers in Oncology
Type at least 3 characters
3,167 articles
articles
Review
Published on 10 Apr 2026
Bidirectional regulation of the ubiquitin-RNA modification axis in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1761698
- 128 views
Review
Accepted on 09 Apr 2026
Perineural Invasion in Solid Tumors: Biological Foundations and the Emerging Integration of Machine Learning and Artificial Intelligence
in Molecular and Cellular Oncology
Frontiers in Oncology
Editorial
Accepted on 08 Apr 2026
Editorial: New Insights on Sialic Acid and Sialylated Glycans in the Tumorigenic Process
in Molecular and Cellular Oncology
Frontiers in Oncology
Editorial
Accepted on 08 Apr 2026
Metabolic Cell Death in Cancer: Reprogramming Vulnerabilities into Therapeutic Opportunities
in Molecular and Cellular Oncology
Frontiers in Oncology
Review
Published on 01 Apr 2026
Advances in polyphenol-based strategies for musculoskeletal recovery and exercise rehabilitation in cancer: Mechanistic insights into Wnt/β-catenin and PI3K/Akt signaling pathways and inflammatory markers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1805804
- 136 views
Review
Published on 31 Mar 2026
Hypoxic microenvironment in cancer: role in metabolic reprogramming
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1771365
- 209 views
Original Research
Published on 31 Mar 2026
Systems toxicology unravels multi-tiered carcinogenic networks of zearalenone in gastric cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1762191
- 201 views
Correction
Accepted on 30 Mar 2026
Correction: FGFR2/STAT3 Signaling Pathway Involves in the Development of MMTV-Related Spontaneous Breast Cancer in TA2 Mice
in Molecular and Cellular Oncology
Frontiers in Oncology
Brief Research Report
Published on 30 Mar 2026
Elevated serum omentin levels correlate with tumor aggressiveness and disease progression in breast cancer patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1774692
- 249 views
Original Research
Published on 30 Mar 2026
ESRP2 constrains EMT plasticity associated with ZEB1 expression in bladder cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1764850
- 230 views
Review
Published on 30 Mar 2026
Insight into the emerging role of long non-coding RNAs in BRAF inhibitor resistance in melanoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1757030
- 219 views
Mini Review
Accepted on 27 Mar 2026
miR-17: From Developmental Regulatory Hub to Molecular Engine Driving Tumourigenesis
in Molecular and Cellular Oncology
Frontiers in Oncology
Editorial
Accepted on 27 Mar 2026
Editorial: National Cancer Research Month 2025 - Advances in Detection, Treatment and Therapies in Oncology
in Molecular and Cellular Oncology
Frontiers in Oncology
Review
Published on 27 Mar 2026
The mechanism of the PI3K-AKT-mTOR signaling pathway in renal cell carcinoma: current developments and future prospects
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1745024
- 220 views
Retraction
Accepted on 26 Mar 2026
Retraction: MTA1 Promotes Hepatocellular Carcinoma Progression by Downregulation of DNA-PK-Mediated H1.2T146 Phosphorylation
in Molecular and Cellular Oncology
Frontiers in Oncology
Original Research
Accepted on 25 Mar 2026
An Integrative coding and non-coding SNPs analysis of the CLDN-3 gene in humans to identify high-priority variants using in-silico analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
Review
Accepted on 25 Mar 2026
Targeting TGF-β–driven fibrotic, epigenetic remodeling and Bax/Bcl-2 through polyphenol– exercise synergy: Molecular implications for biomechanical impairment and rehabilitation in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
Original Research
Published on 24 Mar 2026
Comparative omics reveals conserved extracellular matrix signatures during mammary tumor progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1788746
- 214 views
Mini Review
Published on 23 Mar 2026
Integrative molecular diagnostics for HPV-driven cervical carcinogenesis: a translational review of mechanisms and multimodal risk stratification
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1803942
- 196 views
- 1 citation
Original Research
Published on 19 Mar 2026
Machine learning driven LD50 prediction for cancer risk assessment using modern molecular language models
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1788240
- 288 views
Correction
Published on 18 Mar 2026
Correction: Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1821472
Correction
Published on 12 Mar 2026
Correction: A systematic review and exploration of clinical application of Liver depression syndrome in breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1820675
Review
Published on 04 Mar 2026
The dual regulatory role of METTL14-mediated m6A modification in tumorigenesis and its underlying mechanisms
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2026.1771313
- 306 views